Search

Seproxetine

Seproxetine was being investigated by Eli Lilly as an antidepressant but development was never completed and the drug was never marketed.

Cefpiramide

Cefpiramide is a third-generation cephalosporin antibiotic.

Roflumilast

The cream formulation was first approved by the FDA in July 2022 [L42580] and by Health Canada in April 2023. … [L46546] It was first approved by the EMA in July 2010, and by the FDA in January 2018.[L37564] Roflumilast topical cream is indicated to treat plaque psoriasis.

Eteplirsen

Eteplirsen was the first treatment for DMD approved by the FDA.[A244925] … [L40015] Duchenne muscular dystrophy is a rare genetic disorder characterized by progressive muscle deterioration and premature death most commonly due to respiratory or cardiac complications.

Zolazepam

It is around four times the potency of diazepam but it is both water-soluble and un-ionized at physiological pH meaning that its onset is very fast.

Eszopiclone

Eszopiclone was initially approved by the FDA in 2004.[L6769] … One major benefit of eszopiclone is that it is approved by the FDA for the long-term treatment of insomnia.

Ulipristal

The exact mechanism of action for ulipristal is still currently debated, though there is evidence that it functions by inhibiting ovulation.

Soy isoflavones

Desirudin

Common side effects include: Bleeding gums, collection of blood under the skin, coughing up blood, deep, dark purple bruise and difficulty with breathing or swallowing.

Torasemide

[A319] Torasemide was first approved for clinical use by the FDA in 1993.[L5257]